Daewoong Pharmaceutical announces success in developing a new antidiabetic medication and its aims to enter the market in over 50 countries by 2030
- Written by PR Newswire
![]() |
- Delivers new drug for two consecutive years by obtaining product license on "Envlo", Korea's 36th new drug from the Ministry of Food and Drug Safety
- Plans to enter the type 2 diabetes global market worth $71.4 billion
- Provides new and broad treatment options for patients with insufficient blood glucose control with three indications
SEOUL, South Korea...















